Neurocognitive outcomes do not differ with hypotension-, hypertension-avoidance strategies for patients undergoing noncardiac surgery
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
Risk for major adverse cardiac and cerebrovascular events lower compared with aspirin monotherapy for patients who undergo PCI and discontinue DAPT